These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32557803)

  • 1. Timing Is Everything: The T-Cell Response to α-Synuclein Is Maximal in Early Parkinson's.
    Kouli A; Williams-Gray CH
    Mov Disord; 2020 Jul; 35(7):1137. PubMed ID: 32557803
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-synuclein triggers T-cell response. Is Parkinson's disease an autoimmune disorder?
    Bandres-Ciga S; Cookson MR
    Mov Disord; 2017 Sep; 32(9):1327. PubMed ID: 28782845
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of α-Synuclein-Specific T Cells in Parkinson's Disease.
    Dhanwani R; Sette A; Lindestam Arlehamn CS
    Methods Mol Biol; 2022; 2574():123-131. PubMed ID: 36087199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Gallups NJ; Standaert DG; Harms AS
    Brain; 2021 Aug; 144(7):2047-2059. PubMed ID: 33704423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells from patients with Parkinson's disease recognize α-synuclein peptides.
    Sulzer D; Alcalay RN; Garretti F; Cote L; Kanter E; Agin-Liebes J; Liong C; McMurtrey C; Hildebrand WH; Mao X; Dawson VL; Dawson TM; Oseroff C; Pham J; Sidney J; Dillon MB; Carpenter C; Weiskopf D; Phillips E; Mallal S; Peters B; Frazier A; Lindestam Arlehamn CS; Sette A
    Nature; 2017 Jun; 546(7660):656-661. PubMed ID: 28636593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease.
    Caggiu E; Paulus K; Galleri G; Arru G; Manetti R; Sechi GP; Sechi LA
    J Neuroimmunol; 2017 Sep; 310():26-31. PubMed ID: 28778441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
    Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson's disease mice.
    Badr M; McFleder RL; Wu J; Knorr S; Koprich JB; Hünig T; Brotchie JM; Volkmann J; Lutz MB; Ip CW
    J Neuroinflammation; 2022 Dec; 19(1):319. PubMed ID: 36587195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.
    Karikari AA; McFleder RL; Ribechini E; Blum R; Bruttel V; Knorr S; Gehmeyr M; Volkmann J; Brotchie JM; Ahsan F; Haack B; Monoranu CM; Keber U; Yeghiazaryan R; Pagenstecher A; Heckel T; Bischler T; Wischhusen J; Koprich JB; Lutz MB; Ip CW
    Brain Behav Immun; 2022 Mar; 101():194-210. PubMed ID: 35032575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
    Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
    Front Immunol; 2019; 10():303. PubMed ID: 30858851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy.
    Shahnawaz M; Mukherjee A; Pritzkow S; Mendez N; Rabadia P; Liu X; Hu B; Schmeichel A; Singer W; Wu G; Tsai AL; Shirani H; Nilsson KPR; Low PA; Soto C
    Nature; 2020 Feb; 578(7794):273-277. PubMed ID: 32025029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid.
    Kalia LV
    Parkinsonism Relat Disord; 2019 Feb; 59():21-25. PubMed ID: 30466800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
    Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM
    Brain; 2014 Mar; 137(Pt 3):834-48. PubMed ID: 24477431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein: the long distance runner.
    George S; Rey NL; Reichenbach N; Steiner JA; Brundin P
    Brain Pathol; 2013 May; 23(3):350-7. PubMed ID: 23587141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
    Pavlou MAS; Pinho R; Paiva I; Outeiro TF
    Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.